Venous thromboembolism in COVID-19

S Schulman, Y Hu… - Thrombosis and …, 2020 - thieme-connect.com
The coronavirus disease 2019 (COVID-19) is our latest pandemic, preceded by the H1N1
swine flu in 2009, which lasted approximately 19 months. One of the special characteristics …

Post-COVID syndrome: A reflection and opinion paper.

E Bouza, MC Martín Delgado, M Santos Sebastián - 2021 - ddfv.ufv.es
Un elevado porcentaje de las personas que han padecido COVID refieren, tras la
recuperación de la fase aguda de la enfermedad, una serie de manifestaciones clínicas …

[HTML][HTML] Síndrome post-COVID: Un documento de reflexión y opinión

E Bouza, RC Moreno, PDL Ramos… - Revista española de …, 2021 - ncbi.nlm.nih.gov
Un elevado porcentaje de las personas que han padecido COVID refieren, tras la
recuperación de la fase aguda de la enfermedad, una serie de manifestaciones clínicas …

Pharmacologic thromboprophylaxis and thrombosis in hospitalized patients with COVID-19: a pooled analysis

R Patell, T Chiasakul, E Bauer… - Thrombosis and …, 2021 - thieme-connect.com
Background Coronavirus disease 2019 (COVID-19) increases thrombosis in hospitalized
patients prompting adoption of different thromboprophylaxis strategies. Safety and efficacy of …

International alliance and AGREE-ment of 71 clinical practice guidelines on the management of critical care patients with COVID-19: a living systematic review

YS Amer, MA Titi, MW Godah, HA Wahabi… - Journal of clinical …, 2022 - Elsevier
Objective We aimed to systematically identify and critically assess the clinical practice
guidelines (CPGs) for the management of critically ill patients with COVID-19 with the …

Atrial fibrillation as a predictor of mortality in high risk COVID-19 patients: a multicentre study of 171 patients

RJ Ip, A Ali, ZQ Baloch, A Al-Abcha, C Jacob… - Heart, Lung and …, 2021 - Elsevier
Purpose Certain patient demographics and biomarkers have been suggested to predict
survival in patients infected with COVID-19. However, predictors of outcome in patients who …

Adherence of clinical practice guidelines for pharmacologic treatments of hospitalized patients with COVID-19 to trustworthy standards: a systematic review

KEA Burns, M Laird, J Stevenson… - JAMA Network …, 2021 - jamanetwork.com
Importance The COVID-19 pandemic created the need for rapid and urgent guidance for
clinicians to manage COVID-19 among patients and prevent transmission. Objective To …

Twenty years of progress in angiotensin converting enzyme 2 and its link to SARS-CoV-2 disease

CM Ferrario, S Ahmad, L Groban - Clinical Science, 2020 - portlandpress.com
The virulence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection and the aggressive nature of the disease has transformed the universal pace of …

COVID-19 thromboprophylaxis. New evidence

R Ferrandis, P Sierra, A Gomez-Luque - Revista Española de …, 2024 - Elsevier
Recent publications have questioned the efficacy of using therapeutic or intermediate doses
of low molecular weight heparin (LMWH) in COVID-19 patients, especially in the most …

[HTML][HTML] A Delphi consensus on the management of anticoagulation in the COVID-19 pandemic: the MONACO study

C Escobar, RB Freire, XGM Marimón… - Cardiovascular …, 2023 - ncbi.nlm.nih.gov
Background During the COVID-19 pandemic, guideline documents on the management of
anticoagulation were rapidly published. However, these documents did not follow a …